As of 2025-08-02, the Fair Value of CytoTools AG (T5O.DE) is -1.31 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.78 EUR, the upside of CytoTools AG is -146.97%.
With the market price of 2.78 EUR and our fair value calculation, CytoTools AG (T5O.DE) is not a good investment. Investing in T5O.DE stocks now will result in a potential loss of 146.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -1.42 | -1.27 | -1.84 | -4.06 | -0.83 | -1.88 |
| YoY growth | -33.46% | 10.32% | -44.26% | -120.69% | 79.56% | -21.71% |
| Market Cap (mil) | 7.03 |
| P/E | |
| Forward P/E |
| EPS | -0.26 |
| Avg earnings growth rate | -21.71% |
| TTM earnings | -0.66 |